High Hematocrit Symptoms: Causes, Signs & What to Do
High hematocrit (erythrocytosis) thickens the blood and raises clotting risk, from common causes like dehydration and altitude to polycythemia vera. This page covers the specific symptoms, likely causes, normal ranges, and when to act.
Hematocrit is the percentage of blood volume occupied by red blood cells. High hematocrit (above 52% in men, above 48% in women) increases blood viscosity — making the blood thicker and more prone to clotting. The most common causes are dehydration (which concentrates red cells without actually producing more of them) and chronic hypoxia (low oxygen states that stimulate the bone marrow to produce more red cells). Polycythemia vera, a myeloproliferative neoplasm, is a less common but important primary cause. See the Hematocrit biomarker overview for how it relates to hemoglobin and RBC count.
What High Hematocrit Means
Hematocrit reflects the ratio of red blood cells to plasma volume. It rises when red blood cell mass increases (true erythrocytosis) or when plasma volume decreases (relative/spurious erythrocytosis from dehydration). The distinction matters clinically: dehydration-related high hematocrit resolves with rehydration; true erythrocytosis from polycythemia vera or chronic hypoxia requires specific evaluation and treatment. Blood viscosity is directly proportional to hematocrit — at values above 55%, blood flow slows significantly in small vessels, increasing the risk of thrombosis.
Symptoms of High Hematocrit
From hyperviscosity (thickened blood) — present in significant erythrocytosis from any cause:
- Headache — often dull, persistent, worse in the morning
- Dizziness and lightheadedness
- Blurred or double vision (from impaired microvascular flow to the retina)
- Flushed or ruddy complexion (plethora)
- Fatigue and weakness despite high red cell mass (paradoxically, too-thick blood delivers oxygen less efficiently)
- Tingling or burning in hands and feet
From polycythemia vera specifically:
- Aquagenic pruritus — intense itching after a warm shower or bath (a hallmark of PV from histamine release by mast cells)
- Splenomegaly causing left-sided abdominal fullness and early satiety
- Erythromelalgia — burning pain and redness of the hands or feet from small vessel thrombosis
- Increased risk of DVT, pulmonary embolism, stroke, and TIA
From the underlying cause (secondary erythrocytosis):
- Shortness of breath and cough (COPD, pulmonary fibrosis — hypoxia drives EPO production)
- Sleep apnea symptoms (snoring, daytime fatigue, witnessed apneas)
What Causes High Hematocrit
Secondary erythrocytosis (appropriate elevation from hypoxia or EPO stimulus):
- Dehydration — the most common cause; plasma volume falls, concentrating red cells
- Altitude exposure — low atmospheric oxygen stimulates erythropoietin (EPO) production to increase red cell mass
- Chronic obstructive pulmonary disease (COPD) — chronic hypoxia drives excess EPO
- Sleep apnea — nocturnal hypoxia is a common underdiagnosed cause
- Smoking — carbon monoxide from cigarettes reduces functional oxygen delivery, triggering compensatory erythrocytosis
- Congenital heart disease with right-to-left shunting
EPO-mediated:
- Erythropoietin-secreting tumors (renal cell carcinoma, hepatocellular carcinoma, cerebellar hemangioblastoma) — rare
- Exogenous EPO use (performance-enhancing doping)
- Testosterone therapy — stimulates erythropoiesis
Primary erythrocytosis:
- Polycythemia vera (PV) — myeloproliferative neoplasm caused by JAK2 V617F mutation; EPO is suppressed (unlike secondary causes); the bone marrow produces excess red cells autonomously
Normal Hematocrit Levels
| Group | Reference Range | |---|---| | Men | 38.3-48.6% | | Women | 35.5-44.9% | | High concern (men) | Above 52% | | High concern (women) | Above 48% | | Polycythemia vera typical range | Above 60% in many cases |
The first step when hematocrit is above 52% in men or 48% in women is to check whether it persists on repeat testing (ruling out dehydration) and to measure serum EPO to distinguish primary (PV, EPO suppressed) from secondary (EPO elevated or normal) erythrocytosis.
When to See Your Care Team
Book a 1:1 consultation with a licensed care team lead for hematocrit consistently above the sex-specific upper limit. The essential workup includes a repeat CBC after adequate hydration, serum EPO level, and review for hypoxia risk factors (smoking, sleep apnea, COPD). If EPO is low or normal alongside high hematocrit, JAK2 V617F mutation testing is indicated to evaluate for polycythemia vera. Hematocrit above 55% in anyone is a high-priority referral to hematology.
Frequently Asked Questions
Does dehydration cause a high hematocrit?
Yes. When plasma volume decreases from dehydration, the proportion of blood volume occupied by red cells (hematocrit) increases even though the total number of red cells has not changed. This is relative or spurious erythrocytosis. A repeat CBC after adequate rehydration should normalize the hematocrit if dehydration was the sole cause.
Can testosterone therapy raise hematocrit?
Yes, significantly. Testosterone stimulates erythropoietin production by the kidneys and directly stimulates bone marrow red cell production. Erythrocytosis is the most common serious adverse effect of testosterone replacement therapy. Guidelines recommend checking hematocrit before starting TRT and monitoring it at 3-6 months and annually thereafter. If hematocrit exceeds 52-54%, dose reduction, changing to a lower-absorbing formulation (transdermal vs. injectable), or therapeutic phlebotomy are considered.
What is polycythemia vera and how is it different from other causes?
Polycythemia vera is a clonal bone marrow disorder where a mutation (usually JAK2 V617F) causes the red cell precursors to proliferate autonomously without needing EPO stimulation. Unlike secondary erythrocytosis (where EPO is elevated from hypoxia), EPO is low in PV because the feedback loop is overridden. PV is diagnosed by the combination of high hematocrit/hemoglobin, low EPO, and JAK2 mutation. It is managed with phlebotomy, low-dose aspirin, and sometimes cytoreductive therapy (hydroxyurea, ruxolitinib).
Is high hematocrit dangerous?
At significant elevations, yes. Hematocrit above 55% markedly increases blood viscosity and the risk of arterial and venous thrombosis — including stroke, heart attack, DVT, and pulmonary embolism. Polycythemia vera in particular carries a 3-4x increased risk of thrombotic events compared to the general population, which is why treatment targets a hematocrit below 45%.
